(MNTA/ABBV)—CHRS seeks IPRs on four more Humira patents: http://www.bigmoleculewatch.com/2017/01/31/coherus-files-four-petitions-for-inter-partes-review-of-abbvies-adalimumab-related-patent/ See #msg-126385726 and #msg-118781959 for related info.